NCT04294147: A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist
- State
- Completed
- Phase
- Phase 4
- People
- 65 taking part
- Started
- 6 Oct 2020
- Primary completion
- 5 Mar 2021
- Arms
- Galcanezumab
- Results
- Posted on the registry
- 3 Mar 2020: Trial registered
- 6 Oct 2020: Trial started
- 5 Mar 2021: Trial completed
- 22 Mar 2022: Trial results posted